e-learning
resources
Munich 2006
Sunday 03.09.2006
Immunology of the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia
K. Kändler, K. Rüttger, R. Bals (Marburg, Germany)
Source:
Annual Congress 2006 - Immunology of the airways
Session:
Immunology of the airways
Session type:
Oral Presentation
Number:
1680
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Kändler, K. Rüttger, R. Bals (Marburg, Germany). The antimicrobial peptide CRAMP is a regulator of inflammation during pneumonia. Eur Respir J 2006; 28: Suppl. 50, 1680
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Definition and history of sarcoidosis
Related content which might interest you:
Involvement of lymphocytes in
mycoplasma pneumoniae
pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007
Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function
Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma
Year: 2006
Mycolic acid from
mycobacterium tuberculosis
suppresses experimental asthma by triggering the local induction of regulatory T cells
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006
Cellular changes in BAL fluid may reflect immunity in patients with lung cancer
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Inflammatory response to infectious pulmonary injury
Source: Eur Respir J 2003; 22: 10S-14S
Year: 2003
MTB-specific lymphocytes are selectively recruited to the site of infection in active pulmonary tuberculosis
Source: Annual Congress 2007 - Immunology and genetics of tuberculosis
Year: 2007
Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia
Source: Eur Respir J 2009; 33: 375-381
Year: 2009
Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Airway inflammation: assessment of neutrophil apoptosis in induced sputum
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
Impact of
Pseudomonas aeruginosa
infection on Na
+
transport in airway epithelia
Source: Annual Congress 2007 - The impact of viral and bacterial infection on the respiratory epithelium
Year: 2007
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia
Source: Eur Respir J 2011; 38: 1158-1164
Year: 2011
The impact of time on the systemic inflammatory response in pneumococcal pneumonia
Source: Eur Respir J 2010; 35: 614-618
Year: 2010
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Source: Eur Respir J 2012; 40: 1458-1467
Year: 2012
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
Lysozyme level and activity are decreased in the lungs of patients with idiopathic pulmonary fibrosis (IPF) and potentially contribute to increased susceptibility to pulmonary infection
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006
Bronchial inflammatory changes in wheezy infants
Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children
Year: 2007
Endogenous mediators of resolution
Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts
Year: 2006
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
Source: Eur Respir J 2011; 37: 53-64
Year: 2011
Neomacrolides in airway disease
Source: Annual Congress 2005 - New developments in infectious disease
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept